NO20090748L - Fremgangsmate for rensing av montelukast - Google Patents

Fremgangsmate for rensing av montelukast

Info

Publication number
NO20090748L
NO20090748L NO20090748A NO20090748A NO20090748L NO 20090748 L NO20090748 L NO 20090748L NO 20090748 A NO20090748 A NO 20090748A NO 20090748 A NO20090748 A NO 20090748A NO 20090748 L NO20090748 L NO 20090748L
Authority
NO
Norway
Prior art keywords
montelukast
comprised
organic solvent
impurities
mixture
Prior art date
Application number
NO20090748A
Other languages
English (en)
Norwegian (no)
Inventor
Montserrat Monsalvatje Llagostera
Pedro Talavera Escasany
Yolanda Gasanz Guillen
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of NO20090748L publication Critical patent/NO20090748L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20090748A 2006-08-09 2009-02-17 Fremgangsmate for rensing av montelukast NO20090748L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83687306P 2006-08-09 2006-08-09
EP06118689A EP1886997A1 (fr) 2006-08-09 2006-08-09 Procédé de purification de montelukast
PCT/EP2007/058176 WO2008017667A1 (fr) 2006-08-09 2007-08-07 Procédé de purification du montélukast

Publications (1)

Publication Number Publication Date
NO20090748L true NO20090748L (no) 2009-03-09

Family

ID=37667497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090748A NO20090748L (no) 2006-08-09 2009-02-17 Fremgangsmate for rensing av montelukast

Country Status (19)

Country Link
US (1) US20100029945A1 (fr)
EP (2) EP1886997A1 (fr)
JP (1) JP2010500324A (fr)
KR (1) KR20090037445A (fr)
CN (1) CN101490005B (fr)
AT (1) ATE499345T1 (fr)
AU (1) AU2007283613A1 (fr)
CA (1) CA2657017A1 (fr)
DE (1) DE602007012728D1 (fr)
ES (1) ES2361239T3 (fr)
HR (1) HRP20110322T1 (fr)
IL (1) IL195622A (fr)
MX (1) MX2008015135A (fr)
NO (1) NO20090748L (fr)
PL (1) PL2066638T3 (fr)
PT (1) PT2066638E (fr)
RU (1) RU2009108271A (fr)
SI (1) SI2066638T1 (fr)
WO (1) WO2008017667A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2925145A1 (fr) 2003-07-07 2005-01-13 Insurance Services Office, Inc. Systeme d'information routiere
ES2358923T3 (es) 2005-07-05 2011-05-16 Teva Pharmaceutical Industries, Ltd. Purificación de montelukast.
EP2552892A1 (fr) 2010-03-31 2013-02-06 KRKA, D.D., Novo Mesto Synthèse efficace pour la préparation de montélukast et nouvelle forme cristalline d'intermédiaires dans celle-ci
JP5553096B2 (ja) * 2012-08-29 2014-07-16 大日本印刷株式会社 高純度モンテルカストの製造法
CN103570619B (zh) * 2013-11-08 2015-12-09 南京靖龙药物研发有限公司 一种孟鲁司特钠衍生物的制备方法
CN105646344B (zh) * 2016-02-29 2018-08-14 山东新时代药业有限公司 一种孟鲁司特的纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050107612A1 (en) * 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
WO2005074935A1 (fr) * 2004-01-30 2005-08-18 Teva Pharmaceutical Industries Ltd. Polymorphes d'acide sans montelukast
CA2554927A1 (fr) * 2004-02-03 2005-08-18 Chemagis Ltd. Formes amorphes stables de montelukast sodique
US7189853B2 (en) * 2004-04-15 2007-03-13 Dr. Reddy's Laboratories Limited Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
EP1817289A1 (fr) * 2004-11-30 2007-08-15 Medichem, S.A. Nouveau procede de preparation d'un antagoniste de leucotriene
WO2006064269A2 (fr) * 2004-12-17 2006-06-22 Cipla Limited Sels d'antagoniste de leukotriene

Also Published As

Publication number Publication date
JP2010500324A (ja) 2010-01-07
KR20090037445A (ko) 2009-04-15
EP2066638B1 (fr) 2011-02-23
AU2007283613A1 (en) 2008-02-14
RU2009108271A (ru) 2010-09-20
MX2008015135A (es) 2008-12-15
ES2361239T3 (es) 2011-06-15
ATE499345T1 (de) 2011-03-15
CN101490005A (zh) 2009-07-22
IL195622A (en) 2011-03-31
US20100029945A1 (en) 2010-02-04
CA2657017A1 (fr) 2008-02-14
DE602007012728D1 (de) 2011-04-07
CN101490005B (zh) 2011-08-31
PT2066638E (pt) 2011-05-16
IL195622A0 (en) 2009-09-01
EP2066638B8 (fr) 2011-10-12
EP2066638A1 (fr) 2009-06-10
SI2066638T1 (sl) 2011-06-30
HRP20110322T1 (hr) 2011-06-30
EP1886997A1 (fr) 2008-02-13
PL2066638T3 (pl) 2011-07-29
AU2007283613A8 (en) 2009-01-22
WO2008017667A1 (fr) 2008-02-14

Similar Documents

Publication Publication Date Title
NO20090748L (no) Fremgangsmate for rensing av montelukast
AR047498A1 (es) Proceso de extraccion para remocion de impurezas de una corriente de purga oxidante en la sintesis de acido carboxilico
ATE479703T1 (de) Verfahren zur rückgewinnung von polymyxin b aus einer fermentationsbrühe
EA201070811A1 (ru) Способы и композиции для удаления примесей и воды из способа байера
RU2011106794A (ru) Способы экстракции и очистки промежуточного продукта получения сукралозы
NZ592385A (en) Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof
HK1087109A1 (en) Process for isolation and purification of paclitaxel from natural sources
BR0207803A (pt) processo para recuperação e purificação de caprolactama a partir de um solvente orgánico
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
ATE445574T1 (de) Behandlung von wässrigen flüssigkeiten und herstellung von anthranilsäure
EA201100445A1 (ru) Промывка органической фазы, содержащей капролактам
FR2921565B1 (fr) Procede de recuperation d'acides fluorocarboxyliques
AR064357A1 (es) Purificacion de bisulfito de una alfa-ceto
DE60104685D1 (de) Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetil
TW200626222A (en) Purification method of terephthal aldehyde
WO2006022904A3 (fr) Elimination d'esters d'alcanesulfonates d'alkyle hors d'acides alcanesulfoniques et d'autres milieux organiques
DE602006009269D1 (de) Verfahren zur herstellung von eptifibatid
BR112012013551A2 (pt) processo para processar água residual de processo alcalina.
BR0111412A (pt) Processos para recuperar um ácido orgânico ou um sal de metal do mesmo de uma fase alcoólica
CN104277052A (zh) 一种左氧氟沙星或氧氟沙星的合成方法
JP2009007257A (ja) ケルセチン含有植物材料を用いたケルセチンスルホン酸の製造方法
ATE501145T1 (de) Narkotinreinigungsverfahren
ATE457304T1 (de) Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle
TH114168A (th) วิธีการสำหรับการสกัดและการทำให้สารตัวกลางซูคราโลสบริสุทธิ์
RU2010130965A (ru) Способ ацилирования аминов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application